Japanese Airlines Stock News

Earlier this month, Mahindra Lifespace Developers announced a joint venture with Mitsui Fudosan Group to develop Mahindra Blossom, a 730‑home premium, net zero waste residential project in Bengaluru’s Whitefield corridor, while Mitsui Fudosan also reported higher nine‑month revenue of ¥1.98 trillion and net income of ¥219.87 billion alongside updated full‑year forecasts and a planned treasury share cancellation. The combination of stronger earnings guidance, share cancellation plans, and...

If you are wondering whether Yamaha's current share price around ¥1,217 offers good value, this article will walk through what the numbers are really saying about the stock. The share price performance has been mixed, with a 0.3% decline over the last 7 days, a 4.5% gain over 30 days, 10.8% year to date, and 16.1% over 1 year, set against weaker 3 year and 5 year returns of 22.6% and 35.2% declines. Recent coverage of Yamaha has focused on its position in consumer durables and how investors...

Soft earnings didn't appear to concern Cross Marketing Group Inc.'s ( TSE:3675 ) shareholders over the last week. We...

Yamaha Motor Co., Ltd. recently reported its Q4 2025 results, cut its dividend for the fiscal year to ¥10 per share from ¥25, and issued new earnings guidance for 2026 including expected revenue of ¥2.70 trillion and basic earnings per share of ¥103.05. At the same time, the company outlined a rebound in shareholder returns with projected dividends of ¥25 per share for 2026, signaling a recalibration of its payout after the 2025 reduction. We’ll now examine how Yamaha Motor’s fresh 2026...

Takashimaya Company (TSE:8233) has drawn fresh attention after reporting January 2026 sales results, with year on year changes of 5.5% for the company overall and 6.7% across its 14 stores. See our latest analysis for Takashimaya Company. That sales update comes as the share price has had a strong run, with a 30 day share price return of 20.17% and a 90 day gain of 39.88%. The 1 year total shareholder return of 90.13% and 5 year total shareholder return of over 3.5x suggest momentum has been...

JFE Holdings (TSE:5411) is back in focus after reporting earnings for the nine months to December 31, 2025, with both sales and net income lower than in the same period a year earlier. See our latest analysis for JFE Holdings. The earnings update comes after a strong 90 day share price return of 23.63% and a 1 year total shareholder return of 31.77%. However, recent softness, including a 7 day share price return decline of 4.09%, hints that momentum has cooled slightly. If results like these...

Earnings and guidance put Maruichi Steel Tube in focus Maruichi Steel Tube (TSE:5463) is back on investors’ radar after reporting nine month earnings to December 31, 2025, showing lower sales but higher net income, and updating full year guidance through March 31, 2026. See our latest analysis for Maruichi Steel Tube. The latest earnings and guidance appear to have kept interest in Maruichi Steel Tube alive, with the share price at ¥1,605 and a 90 day share price return of 17.15%, alongside a...

SMC (TSE:6273) is in focus after releasing nine month results to December 31, 2025, alongside updated full year guidance, giving investors clearer visibility on sales, profit and earnings expectations. See our latest analysis for SMC. The nine month earnings update and full year guidance appear to be the key drivers behind SMC's recent momentum, with a 12.93% 1 month share price return and a 40.35% 3 month share price return. The 1 year total shareholder return of 36.38% points to a trend...

Mitsubishi Motors reported past nine‑month results to December 31, 2025 showing sales of ¥1,976,533 million and a net loss of ¥4,489 million, while also revising its full‑year fiscal 2026 guidance to higher expected net sales of ¥2,900,000 million with unchanged profit targets. The combination of weaker recent profitability and a higher full‑year sales forecast highlights a tension between short‑term earnings pressure and management’s confidence in demand trends. We’ll now examine how...

In February 2026, Kobe Steel, Ltd. reported nine‑month results showing lower sales and profit year on year and revised its consolidated full‑year outlook to net sales of JPY 2,440.00 billions and operating profit of JPY 130.00 billions, alongside reduced non‑consolidated guidance. The company linked its downgrade to weaker demand in automotive, construction and semiconductor‑related materials, softer steel market spreads, reduced dividends from group companies, and more negative inventory...

Trend Micro’s FY 2025 Earnings Snapshot Trend Micro (TSE:4704) has just posted its FY 2025 third quarter numbers, with revenue of ¥68,844 million and EPS of ¥95.60, as investors weigh these figures against a year where earnings rose 43.3% and net profit margin moved from 9.1% to 12.8%. Over the past few quarters, revenue has ranged between about ¥66,408 million and ¥69,980 million while quarterly EPS has moved between roughly ¥41.69 and ¥67.46 before reaching the latest ¥95.60 print. This...

If you are wondering whether Advantest is still attractively priced after a huge run, this article will walk through what the current share price could mean for long term investors. The stock last closed at ¥26,960, with returns of 21.7% over 30 days, 27.3% year to date and 182.2% over 1 year, while the 3 year and 5 year returns are very large. Recent headlines have focused on Advantest's role in semiconductor testing equipment and its exposure to trends such as artificial intelligence...

As global markets navigate the complexities of AI disruption and fluctuating economic indicators, the Asian market presents a unique landscape for investors seeking opportunities in under-the-radar stocks. With key indices showing varied performances and economic conditions evolving, identifying a good stock often involves looking at companies with strong fundamentals that can adapt to technological changes and shifting consumer demands.

In early February 2026, Astellas Pharma raised its full-year revenue and profit guidance, citing stronger global sales of XTANDI and Mirabegron and favorable foreign exchange effects, while also resolving all U.S. Myrbetriq patent litigation through settlements totaling US$210,000,000 in cash and license payments from Lupin and Zydus. Shortly afterward, Evinova announced an AI-powered clinical development collaboration with Astellas, AstraZeneca and Bristol Myers Squibb, highlighting...

Kubota Corporation’s board meeting on February 12, 2026 approved a year-end dividend of ¥25 per share for 2025, confirmed capital infusion of ₹5 billion into Escorts Kubota Finance, and advanced stock-based compensation plans using treasury shares. On the same day, Kubota reported full-year 2025 earnings with slightly higher sales but lower net income, while issuing 2026 guidance that includes higher dividend expectations, highlighting a continued emphasis on shareholder returns despite...

Shareholders might have noticed that Bridgestone Corporation ( TSE:5108 ) filed its annual result this time last week...

As global markets grapple with AI disruption concerns and fluctuating economic indicators, Asia presents a unique landscape where small-cap stocks are gaining attention amidst broader market shifts. In this context, identifying promising stocks involves looking for companies that demonstrate resilience and adaptability in changing environments, often characterized by innovative strategies or niche market positions.

There's been a notable change in appetite for PeptiDream Inc. ( TSE:4587 ) shares in the week since its yearly report...

The market for Toray Industries, Inc.'s ( TSE:3402 ) shares didn't move much after it posted weak earnings recently. We...

The market was pleased with the recent earnings report from Bando Chemical Industries, Ltd. ( TSE:5195 ), despite the...

Earlier this month, Takeda Pharmaceutical announced that the U.S. FDA accepted its New Drug Application and granted Priority Review for orexin agonist Oveporexton (TAK-861) in narcolepsy type 1, with a PDUFA decision expected in the third quarter of this year. This development highlights Takeda’s push into orexin-targeted neuroscience, aiming to address persistent symptoms in narcolepsy type 1 where many patients remain insufficiently treated. We’ll now examine how the FDA’s Priority Review...

Japan Tobacco Inc. recently reported full-year 2025 results, with sales rising to ¥3,467.68 billion and net income reaching ¥510.18 billion, while also confirming a fiscal year-end 2025 dividend of ¥130.00 per share, up from ¥97.00, payable on March 26, 2026. At the same time, the company guided to slightly lower full-year 2026 dividends of ¥121.00 per share and issued new forecasts calling for ¥3,697.00 billion in revenue and ¥570.00 billion in profit attributable to owners, reshaping...

SEIKOH GIKEN Co., Ltd. ( TSE:6834 ) shareholders will have a reason to smile today, with the analysts making...

Ai Robotics (TSE:247A) has just posted Q3 2026 results with revenue of ¥8.0b and basic EPS of ¥20.11, alongside trailing 12 month EPS of ¥38.34 that reflects reported earnings growth of 53.9% over the past year. The company has seen revenue move from ¥3.7b in Q4 2025 to ¥6.0b in Q2 2026 and ¥8.0b in Q3 2026, while quarterly EPS shifted from ¥9.65 to ¥7.86 and then ¥20.11 over the same period. This sits against a trailing net profit margin of 10.3% compared with 11.9% a year earlier. For...